Sanofi (SNYNF) stock
SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
$78.48−0.07 (-0.09%)
Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –
Sanofi gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was €33.67B, up 8.3% from the year before. Over ten years it grew 3.5% a year on average. The highest annual figure on record is €33.67B in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €33.67B | +8.3% |
| FY2024 | Dec 31, 2024 | €31.08B | +7.2% |
| FY2023 | Dec 31, 2023 | €28.99B | +1.1% |
| FY2022 | Dec 31, 2022 | €28.68B | +6.5% |
| FY2021 | Dec 31, 2021 | €26.92B | +6.8% |
| FY2020 | Dec 31, 2020 | €25.21B | -1.7% |
| FY2019 | Dec 31, 2019 | €25.65B | +5.8% |
| FY2018 | Dec 31, 2018 | €24.24B | -1.5% |
| FY2017 | Dec 31, 2017 | €24.61B | +2.6% |
| FY2016 | Dec 31, 2016 | €24.00B | +0.2% |
| FY2015 | Dec 31, 2015 | €23.94B | – |
See a number that looks wrong?